Zero to Hero? Scope 3 Emissions – A Strategic Imperative for Pharma Companies Verena Ahnert Read more
Executive Insights Life Sciences & Pharma Animal Pharma: Unlocking Value Through Growth and Investment May 21, 2025
Smart Chart Life Sciences & Pharma Look Forward 2025: Proving AI’s Value in Life Sciences January 22, 2025
Article Life Sciences & Pharma AI and Biopharma: New Solutions Emerging Across the US Value Chain December 6, 2024
Article Healthcare Services Healthcare Crossroads? The 2024 Election and What’s Really at Stake October 29, 2024
Executive Insights Life Sciences & Pharma Understanding the Inflation Reduction Act Negotiation Prices After the Dust Has Settled September 27, 2024
Video / Webinar Life Sciences & Pharma Contrasting China's Market Dynamics with Global Pharma Giants August 16, 2024